Relay Therapeutics RLAY
NASDAQ RLAY
$18.49 +0.44 (+2.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Other Operating Expenses (2021 - 2026)

Updated

Relay Therapeutics (RLAY) recorded Other Operating Expenses of $53,000 in Q1 2026, up 488.9% from $9,000 a year earlier.

Analysis

Relay Therapeutics (RLAY) Other Operating Expenses (2021 - 2026) Analysis & Trends

For FY2024, Relay Therapeutics reported Other Operating Expenses of -$13.21 million.

  • Across earlier years, Other Operating Expenses came in at -$6.42 million in FY2023, -$11.68 million in FY2022 and $137.69 million in FY2021.
  • The Q1 2026 figure is the highest quarterly Other Operating Expenses since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Relay Therapeutics 3.94 Bn 3.94 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 53,000.00
Mar 31, 2025 9,000.00
Jun 30, 2024 -11.37 Mn
Mar 31, 2024 -1.83 Mn
Dec 31, 2023 -2.07 Mn
Sep 30, 2023 -1.20 Mn
Jun 30, 2023 -2.15 Mn
Mar 31, 2023 -1.00 Mn
Dec 31, 2022 -10.54 Mn
Sep 30, 2022 3.26 Mn
Jun 30, 2022 200,000.00
Mar 31, 2022 -4.60 Mn
Dec 31, 2021 836,000.00
Sep 30, 2021 2.00 Mn
Jun 30, 2021 134.86 Mn
API Access

Relay Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RLAY&period=max&api_key=YOUR_API_KEY